Presentation TCT 2016 PCI Pharmacotherapy Considerations in Patients With Complicating Co-morbidities (CKD, Liver Disease, ASA Allergy, Prior Stroke, Thrombocytopenia) Presenter: Sorin J. Brener, Franz-Josef Neumann, Sunil V. Rao October 30, 2016
News Industry News Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin August 25, 2016
News Daily News Más de la Mitad de los Estudios sobre ECV Excluyen a Pacientes con Enfermedad Renal Michael O'Riordan December 03, 2015
News Daily News Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease L.A. McKeown September 28, 2015
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015
News Daily News El Método Elegido para Calcular la Función Renal Pre-PCI es Relevante L.A. McKeown June 29, 2015
Presentation Choice of eGFR Equation Impacts Drug-Dosing Recommendations and Risk Stratification in CKD Patients Undergoing PCI Presenter: J. Parsh June 26, 2015
News Daily News For CKD Patients, CABG Favored Long-term Over PCIEn Pacientes con ERC, la CABG fue Más Favorable a Largo Plazo que la PCI Yael L. Maxwell January 28, 2015
News Daily News A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD May 07, 2014
News Daily News RE-LY: Dabigatran Safe, Effective Across Range of Renal Function Yael L. Maxwell December 30, 2013
News Daily News RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal Yael L. Maxwell December 30, 2013
News Daily News La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias L.A. McKeown September 18, 2012
News Daily News Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD L.A. McKeown September 18, 2012